Anti-SCN5A/ CDCD2/ CMD1E monoclonal antibody

Anti-SCN5A/ CDCD2/ CMD1E antibody for FACS & in-vivo assay

Target products collectionGo to SCN5A/SCN5A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T39716-Ab-1/ GM-Tg-hg-T39716-Ab-2Anti-Human SCN5A monoclonal antibodyHuman
GM-Tg-rg-T39716-Ab-1/ GM-Tg-rg-T39716-Ab-2Anti-Rat SCN5A monoclonal antibodyRat
GM-Tg-mg-T39716-Ab-1/ GM-Tg-mg-T39716-Ab-2Anti-Mouse SCN5A monoclonal antibodyMouse
GM-Tg-cynog-T39716-Ab-1/ GM-Tg-cynog-T39716-Ab-2Anti-Cynomolgus/ Rhesus macaque SCN5A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T39716-Ab-1/ GM-Tg-felg-T39716-Ab-2Anti-Feline SCN5A monoclonal antibodyFeline
GM-Tg-cang-T39716-Ab-1/ GM-Tg-cang-T39716-Ab-2Anti-Canine SCN5A monoclonal antibodyCanine
GM-Tg-bovg-T39716-Ab-1/ GM-Tg-bovg-T39716-Ab-2Anti-Bovine SCN5A monoclonal antibodyBovine
GM-Tg-equg-T39716-Ab-1/ GM-Tg-equg-T39716-Ab-2Anti-Equine SCN5A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T39716-Ab-1/ GM-Tg-hg-T39716-Ab-2; GM-Tg-rg-T39716-Ab-1/ GM-Tg-rg-T39716-Ab-2;
GM-Tg-mg-T39716-Ab-1/ GM-Tg-mg-T39716-Ab-2; GM-Tg-cynog-T39716-Ab-1/ GM-Tg-cynog-T39716-Ab-2;
GM-Tg-felg-T39716-Ab-1/ GM-Tg-felg-T39716-Ab-2; GM-Tg-cang-T39716-Ab-1/ GM-Tg-cang-T39716-Ab-2;
GM-Tg-bovg-T39716-Ab-1/ GM-Tg-bovg-T39716-Ab-2; GM-Tg-equg-T39716-Ab-1/ GM-Tg-equg-T39716-Ab-2
Products NameAnti-SCN5A monoclonal antibody
Formatmab
Target NameSCN5A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SCN5A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SCN5A/ CDCD2/ CMD1E VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T39716
    Target NameSCN5A
    Gene ID6331,20271,25665,695085,403497,101100994,282061,100034027
    Gene Symbol and SynonymsCDCD2,CMD1E,CMPD2,HB1,HB2,HBBD,HH1,ICCD,IVF,LQT3,mH1,Nav1.5,Nav1.5c,PFHB1,RATRSKM2X,rSkM2,RSKM2X,SCAL,Scn2x,SCN5A,SkM1,SkM2,SSS1,VF1
    Uniprot AccessionQ14524,P15389
    Uniprot Entry NameSCN5A_HUMAN,SCN5A_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000183873
    Target ClassificationIon Channel

    The target: SCN5A, gene name: SCN5A, also named as CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1, VF1. The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.